Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung

OBJECTIVE: To study the effects of camrelizumab accompanied by first-line chemotherapy on serum SCC, VEGF levels, and adverse reactions in people undergoing advanced lung squamous cell carcinoma. METHODS: Data sources of the study subjects were 60 people suffering from advanced squamous cell carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zizong, Xuan, Yunpeng, Shao, Yanmei, Zou, Qiang, Cui, Hong, Jin, Xiangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699730/
https://www.ncbi.nlm.nih.gov/pubmed/36438688
http://dx.doi.org/10.1155/2022/3137370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699730/
https://www.ncbi.nlm.nih.gov/pubmed/36438688
http://dx.doi.org/10.1155/2022/3137370

Ejemplares similares